Achilles Therapeutics plc (ACHL) Financials
Stock symbol ACHL is outdated, potentially delisted? Maybe it is available on other exchange?
ACHL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 175.3 million | 21.9 million |
| June 30, 2023 | 197.9 million | 24.1 million |
| March 31, 2023 | 207.6 million | 22.5 million |
| Dec. 31, 2022 | 220.4 million | 23.3 million |
ACHL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | 1.0 million | ? |
| June 30, 2023 | -17946 | 1701 |
| March 31, 2023 | -18307 | 1652 |
| Dec. 31, 2022 | -21.8 million | 1.7 million |
ACHL Net Income
No data available :(
ACHL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 140.1 million | - | 7.4 million |
| June 30, 2023 | 143.7 million | - | 8.6 million |
| March 31, 2023 | 158.5 million | - | 7.6 million |
| Dec. 31, 2022 | 173.3 million | - | 8.6 million |
ACHL Shares Outstanding
ACHL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 61383 | 14.7 million | 4.4 million | - |
| June 30, 2023 | 537 | 13.8 million | 4.3 million | - |
| March 31, 2023 | 454 | 13.9 million | 4.7 million | - |
| Dec. 31, 2022 | 2.1 million | 18.9 million | 4.0 million | - |
ACHL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 1.2 million |
| June 30, 2023 | - | 1.3 million |
| March 31, 2023 | - | - |
| Dec. 31, 2022 | - | 837227 |
ACHL
Price: $1.48
52 week price:
Earnings Per Share: -1.66 USD
P/E Ratio: -0.83
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 354400
Market Capitalization: 56.3 million